1
Concomitant Chemo-radiotherapy Plus VIDL Chemotherapy in NK/T-cell Lymphoma
Condition(s):NK/T-cell Lymphoma of Nasal CavityLast Updated:February 7, 2019Completed
Hide Studies Not Open or Pending
Condition(s):NK/T-cell Lymphoma of Nasal CavityLast Updated:February 7, 2019Completed
Condition(s):NK/T-Cell Lymphoma of Nasal Cavity (Diagnosis); NK/T-Cell Lymphoma of Nasopharynx (Diagnosis)Last Updated:November 8, 2023Recruiting
Condition(s):Immune Checkpoint Inhibitor; Chemotherapy Effect; Epigenetic Disorder; NK/T-cell Lymphoma of Nasal CavityLast Updated:July 7, 2020Recruiting
Condition(s):Natural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeLast Updated:March 18, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.